|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Contact w and exposure to oth communicable diseases
ICD-10 (CM) Code and Descriptor
|
Z20.89 |
Contact with and (suspected) exposure to other communicable diseases
This code is considered unacceptable as a principal diagnosis.
|
Z2089 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 42.59%
|
12.04%
|
7.49%
|
6.34%
|
6.02%
|
6.20%
|
4.29%
|
3.40%
|
3.64%
|
2.23%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z20.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
87811
|
SARS-COV-2 COVID19 W/OPTIC |
25,975
|
25,977
|
|
97530
|
THERAPEUTIC ACTIVITIES |
4,359
|
7,208
|
|
97110
|
THERAPEUTIC EXERCISES |
3,809
|
5,384
|
|
97116
|
GAIT TRAINING THERAPY |
2,098
|
2,779
|
|
87426
|
SARSCOV CORONAVIRUS AG IA |
1,553
|
1,554
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
1,470
|
1,470
|
|
97535
|
SELF CARE MNGMENT TRAINING |
1,425
|
2,836
|
|
U0005
|
INFEC AGEN DETEC AMPLI PROBE |
1,380
|
1,380
|
|
92507
|
TX SP LANG VOICE COMM INDIV |
1,169
|
1,169
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
1,021
|
1,512
|
|
92526
|
ORAL FUNCTION THERAPY |
978
|
978
|
|
87635
|
SARS-COV-2 COVID-19 AMP PRB |
348
|
348
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
198
|
198
|
|
86769
|
SARS-COV-2 COVID-19 ANTIBODY |
170
|
178
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
168
|
168
|
|
97542
|
WHEELCHAIR MNGMENT TRAINING |
152
|
249
|
|
U0004
|
COV-19 TEST NON-CDC HGH THRU |
142
|
142
|
|
G0283
|
ELEC STIM OTHER THAN WOUND |
140
|
140
|
|
G0467
|
FQHC VISIT, ESTAB PT |
137
|
137
|
|
G2025
|
DIS SITE TELE SVCS RHC/FQHC |
131
|
131
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z20.89 related to the following DRG Codes:
795
951
|
